July 8, 2020 / 12:04 PM / in a month

BRIEF-Alnylam Pharmaceuticals And Taiba Group Partner To Commercialize RNAi Therapeutics In The Gulf States

July 8 (Reuters) - Alnylam Pharmaceuticals Inc:

* ALNYLAM PHARMACEUTICALS AND TAIBA GROUP PARTNER TO COMMERCIALIZE RNAI THERAPEUTICS IN THE GULF STATES

* ALNYLAM PHARMACEUTICALS - AGREEMENT BETWEEN ALNYLAM AND TAIBA WILL INITIALLY COVER GULF STATES

* ALNYLAM PHARMACEUTICALS - CO, TAIBA MIDDLE EAST HAVE FORMED A DISTRIBUTION AGREEMENT FOR BOTH ONPATTRO AND GIVLAARI Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below